Enzolytics Inc (ENZC)

[BluE33]

The FDA verifies the identity of NDI 1083...ITV-1

On page 9 and 10 on the file the FDA, identifies this NDI in basically four documents, the fourth document is the patent:

The fourth document referring to the extract or amino acid chain Inactivated Pepsin Fragment that is listed under US Patent Number: US 7479538 Document Kind: B2 Patent Title: Irreversibly-inactivated pepsinogen fragment Named Inventors: ZHABILOV HARRY H Applicants (Assignees): ZHABILOV TRUST Agents: Cislo & Thomas, LLP Filing Date: 7/11/2005 Issue/Pub Date: 1/20/2009 Patent Termination: Expires: 7/11/2025

Page 21 on document Conclusion

Since the discovery of pepsin from porcine and it has been deemed as a safe ingredient for human consumption as affirmed in CFR 184.1595 cite 21, this new ingredient is just a purified version that creates a particular chain of amino acids that are included with in the ones integrating pepsin form porcine and are know to be beneficial and safe for human consumption and can possibly be taken as a supplement in daily ingestion as it may support of the immune system.

https://www.regulations.gov/document?D=FDA-2018-S-0023-0120

Enzolytics is in great shape to go into the European and USA markets, because the treatment has minimum to no side effects, and the industry keeps growing and growing every year...just with basic research, I conclude that this treatment will be of great help to those with HIV/AIDS because it is backed by the FDA...

Unlike Gilead, that has lawsuits because their drugs showed side effects; Enzolytics as a small cap company, will make a difference with those infected, and the cost will be far less than it currently is right now for those getting the virus treatment.

Once Phase IV is completed, Enzolytics will have the permit to mass produce the Immune Therapeutic Vaccine-1
which will be backed by FDA, and that’s where we have the great value of this company.

$ENZC